Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)
CUSIP: 413197104
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 57,644,670
- Total 13F shares
- 47,339,126
- Share change
- -3,982,528
- Total reported value
- $1,304,886,690
- Put/Call ratio
- 30%
- Price per share
- $27.56
- Number of holders
- 292
- Value change
- -$112,498,749
- Number of buys
- 156
- Number of sells
- 112
Quarterly Holders Quick Answers
What is CUSIP 413197104?
CUSIP 413197104 identifies HRMY - Harmony Biosciences Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 413197104:
Top shareholders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
10%
from 13D/G
|
6,736,939
|
$212,887,273 | — | 30 Jun 2025 | |
| Valor Management LLC |
13F
|
Company |
11%
|
6,618,033
|
$209,129,843 | — | 30 Jun 2025 | |
| Marshman Fund Trust II |
3/4/5
13D/G
|
10%+ Owner |
11%
from 13D/G
|
6,051,120
|
$183,364,064 | — | 01 Nov 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.9%
|
5,110,780
|
$161,500,648 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
8.1%
|
4,688,192
|
$148,146,870 | — | 30 Jun 2025 | |
| Andreas Wicki |
3/4/5
|
Director |
—
class O/S missing
|
2,147,943
|
$71,655,378 | — | 12 Dec 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.8%
|
1,629,246
|
$51,484,174 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.7%
|
1,582,176
|
$49,998,503 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
2.6%
|
1,501,420
|
$47,444,872 | — | 30 Jun 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
2.6%
|
1,488,502
|
$47,037,000 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
2.1%
|
1,209,484
|
$38,219,694 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
1,054,348
|
$33,320,820 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.6%
|
929,471
|
$29,371,284 | — | 30 Jun 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.6%
|
906,909
|
$28,658,324 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
758,863
|
$23,980,106 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.3%
|
720,681
|
$22,773,520 | — | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
1.1%
|
644,530
|
$20,367,148 | — | 30 Jun 2025 | |
| Boston Partners |
13F
|
Company |
1.1%
|
605,495
|
$19,397,946 | — | 30 Jun 2025 | |
| venBio Partners LLC |
13F
|
Company |
0.85%
|
489,194
|
$15,458,530 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.76%
|
437,841
|
$13,835,776 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.75%
|
433,935
|
$13,712,347 | — | 30 Jun 2025 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.73%
|
422,919
|
$13,364,240 | — | 30 Jun 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.7%
|
400,947
|
$12,669,925 | — | 30 Jun 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.66%
|
380,155
|
$12,012,898 | — | 30 Jun 2025 | |
| Nan Fung Group Holdings Ltd |
13F
|
Company |
0.64%
|
368,665
|
$11,649,814 | — | 30 Jun 2025 | |
| CAPITAL MANAGEMENT CORP /VA |
13F
|
Company |
0.61%
|
352,566
|
$11,141,086 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.53%
|
307,165
|
$9,706,414 | — | 30 Jun 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.52%
|
302,000
|
$9,543,200 | — | 30 Jun 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.51%
|
293,842
|
$9,285,407 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.49%
|
281,200
|
$8,885,920 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.47%
|
271,435
|
$8,577,358 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.47%
|
270,220
|
$8,538,952 | — | 30 Jun 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.47%
|
269,488
|
$8,516,000 | — | 30 Jun 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.45%
|
261,626
|
$8,267,382 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.44%
|
252,981
|
$7,994,199 | — | 30 Jun 2025 | |
| Man Group plc |
13F
|
Company |
0.44%
|
252,619
|
$7,982,760 | — | 30 Jun 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.43%
|
248,859
|
$7,863,944 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.41%
|
238,888
|
$7,548,861 | — | 30 Jun 2025 | |
| Tieton Capital Management, LLC |
13F
|
Company |
0.41%
|
237,726
|
$7,512,000 | — | 30 Jun 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.4%
|
230,610
|
$7,287,276 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.39%
|
225,169
|
$7,115,341 | — | 30 Jun 2025 | |
| CX Institutional |
13F
|
Company |
0.36%
|
207,783
|
$6,566,000 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.34%
|
193,850
|
$6,125,660 | — | 30 Jun 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.32%
|
186,870
|
$5,973,518 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.32%
|
182,049
|
$5,752,748 | — | 30 Jun 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.3%
|
174,787
|
$5,523,270 | — | 30 Jun 2025 | |
| Jefferies Financial Group Inc. |
13F
|
Company |
0.3%
|
170,570
|
$5,390,012 | — | 30 Jun 2025 | |
| Universal- Beteiligungs- und Servicegesellschaft mbH |
13F
|
Individual |
0.29%
|
168,543
|
$5,325,959 | — | 30 Jun 2025 | |
| Bridge City Capital, LLC |
13F
|
Company |
0.28%
|
162,664
|
$5,140,182 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.28%
|
160,576
|
$5,074,202 | — | 30 Jun 2025 |
Institutional Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q3 2025
As of 30 Sep 2025,
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) was held by
292 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,339,126 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, FMR LLC, DIMENSIONAL FUND ADVISORS LP, AMERICAN CENTURY COMPANIES INC, STATE STREET CORP, LSV ASSET MANAGEMENT, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, Valor Management LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
293
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
276
Q3 2025 holders
292
Holder diff
16
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.